Showing results (1761-1770 of 27,712) with videos related to

Sort By:
Pageof 2,772
Vaccine|November 5, 1999
The immunogenicity in humans of a botulinum type F vaccineV A Montgomery, R S Makuch, J E Brown, et al.
Vaccine|November 5, 1999
Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countriesJ D Wenger, J DiFabio, J M Landaverde, et al.
Vaccine|July 27, 1999
Xenogeneic and allogeneic anti-MHC immune responses induced by plasmid DNA immunizationC S Dela Cruz, J W Chamberlain, K S MacDonald, et al.
Vaccine|July 27, 1999
Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccineG F Rimmelzwaan, M Baars, R van Beek, et al.
Vaccine|July 27, 1999
Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidateC H Kweon, B J Kwon, J G Lee, et al.
Vaccine|July 27, 1999
Antibody responses in humans to an inactivated hantavirus vaccine (Hantavax)H W Cho, C R Howard
Vaccine|July 27, 1999
Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteinsK Cartwright, R Morris, H Rümke, et al.
Vaccine|July 27, 1999
Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretionsJ Ekström, K F Hu, K L Bengtsson, et al.
Vaccine|July 27, 1999
Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoidH Ahman, H Käyhty, A Vuorela, et al.
Vaccine|August 7, 1999
PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systemsA Delgado, E C Lavelle, M Hartshorne, et al.
Pageof 2,772